Table 1 Baseline patient characteristics, N = 35, TMZ - temozolomide.

MGMT methylation status

   • methylated

17

   • not methylated

13

   • unknown

5

Median follow-up (range)

530 days (16 - 1545)

Sex

   • male

22

   • female

13

Median age (range)

62 (33 - 77)

Age

   • < 60 y

14

   • ≥ 60 y

21

Type of resection

   • complete

18

   • incomplete

17

RPA class

   • III

4

   • IV

11

   • V

12

   • not exactly known

8

Re-RT

   • yes

4

   • no

31

Concomitant TMZ

   • yes

26

   • no

7

   • unknown

2

Adjuvant TMZ

   • yes

19

   • no

14

   • unknown

2

Survival

   • long-term

20

   • short-term

15